Infants Fed a Hydrolyzed Infant Formula
Public ClinicalTrials.gov record NCT05369494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tolerance of Infants Fed a Hydrolyzed Infant Formula
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this non-randomized, multi-center study is to evaluate the growth, tolerance and compliance of an extensively hydrolyzed infant formula in an intended use population of infants.
Study identification
- NCT ID
- NCT05369494
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 33 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 0 Days to 90 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 7, 2022 (Actual)
- Primary completion
- Jun 23, 2023 (Actual)
- Completion
- Nov 18, 2023 (Actual)
- Last update posted
- May 1, 2024
2022 – 2023
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Meridian Clinical Research, LLC | Washington D.C. | District of Columbia | 20016 | — |
| AdventHealth Medical Group Pediatrics | Orange City | Florida | 32763 | — |
| Javara Inc. | Fayetteville | Georgia | 72703 | — |
| Meridian Clinical Research 3259 | Macon | Georgia | 31210 | — |
| Springs Medical Research | Owensboro | Kentucky | 42303 | — |
| Meridian Clinical Research 3357 | Charleston | South Carolina | 29407 | — |
| Gentle Pediatrics | Houston | Texas | 77084 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05369494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 1, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05369494 live on ClinicalTrials.gov.